Merck & Co., Inc. (MRK) Stock: Do Analysts Think You Should Buy?

InvestorsObserver is giving Merck & Co., Inc. (MRK) an Analyst Rating Rank of 26, meaning MRK is ranked higher by analysts than 26% of stocks. The average price target for MRK is $90.875 and analyst’s rate the stock as a Buy.

Wall Street analysts are rating MRK a Buy today. Find out what this means to you and get the rest of the rankings on MRK!

See Full MRK Report

Why are Analyst Ratings Important?

You can learn a lot about a company from looking at it’s financial statements and comparing them to other companies. Analysts who cover an industry in depth can add even more to your research though. They typically follow a particular sector or industry very closely. They also pay attention to and ask questions on earnings conference calls and other events where they might learn information that does show up in the numbers. InvestorsObserver takes the average rating from these analysts, and then percentile ranks those averages. This lets you compare stocks in a much more granular way than just seeing the typical five-tiered rating system used on most of Wall Street.

What's Happening With Merck & Co., Inc. Stock Today?

Merck & Co., Inc. (MRK) stock is up 0.7% while the S&P 500 has fallen -0.81% as of 2:13 PM on Tuesday, Jan 25. MRK is higher by $0.56 from the previous closing price of $78.83 on volume of 6,035,302 shares. Over the past year the S&P 500 has risen 13.46% while MRK is higher by 2.60%. MRK earned $2.83 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 27.99. Click Here to get the full Stock Report for Merck & Co., Inc. stock.